Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: Main results of the GUARDIAN trial

Circulation

Volumn 102, Issue 25, 2000, Pages 3032-3038

  Théroux, Pierre ^a,k   Chaitman, B R ^b   Danchin, N ^c   Erhardt, L ^d   Meinertz, T ^e   Schroeder, J S ^f   Tognoni, G ^g   White, H D ^h   Willerson, J T ⁱ   Jessel, A ^j  

^a MONTREAL HEART INSTITUTE   (Canada)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^h GREEN LANE HOSPITAL   (New Zealand)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^j SANOFI   (France)

^k NONE   (Canada)

more..

Author keywords

Cardiopulmonary bypass; Cariporide; Ischemia; Myocardial infarction; Necrosis

Indexed keywords

ANTIPORTER; CARIPORIDE; CREATINE KINASE MB;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANEMIA; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HEADACHE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RANDOMIZED CONTROLLED TRIAL; RASH; RISK MANAGEMENT; STROKE; SURGICAL RISK; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; VERTIGO;

EID: 0034687597     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.25.3032     Document Type: Article

References (14)

1. Protection of the myocardial cell during ischemia
2. The Na-H exchanger, revisited: An update on Na-H and the role of the exchanger in hypertension and exchange regulation cardiac function in health and disease
3. + exchangers of mamalian cells
4. + exchanger in the mammalian cell
5. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia
6. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion
7. Dose dependent reduction of myocardial infarct mass in rabbits bY the NHE-1 inhibitor cariporide (HOE642)
8. A new sodium/hydrogen inhibitor, EMD 85131 limits infarct size in dogs when administered before and after I coronary artery occlusion
9. + exchanger confers greater cardioprotection against 90 minutes of myocardial ischernia than preconditioning in dogs
10. + exchange inhibitor cariporide in patients with anterior myocardial infarction undergoing direct PTCA
11. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty)
12. Methodology of serial ECG classification using a Minnesota code adaptation of the NOVACODE for Q-wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI)
13. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them
14. Importance of bicarbonate transport for protection of cardiomyocytes against reoxygenation injury